Profile
Sheng Wen Yeh is currently Director at Shine-On BioMedical Co., Ltd. since 2022.
Dr. Yeh is also Director at Center Laboratories, Inc. starting in 2025.
Additionally, Dr. Yeh holds the position of General Manager & Associate General Manager at Lumosa Therapeutics Co., Ltd. beginning in 2024.
Dr. Yeh completed a doctorate at the University of Bath, graduate studies at National Taiwan University, and undergraduate studies at National Yang Ming Chiao Tung University.
Sheng Wen Yeh active positions
| Companies | Position | Start |
|---|---|---|
| LUMOSA THERAPEUTICS CO., LTD. | Chief Executive Officer | 14/05/2024 |
| SHINE-ON BIOMEDICAL CO.,LTD. | Director/Board Member | 01/11/2022 |
| CENTER LABORATORIES, INC. | Director/Board Member | 26/06/2025 |
Education of Sheng Wen Yeh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center Laboratories, Inc.
Center Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sales allergen extracts and immunotherapy treatment sets | Health Technology |
Lumosa Therapeutics Co., Ltd.
Lumosa Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in new drug development | Health Technology |
National Yang Ming Chiao Tung University
National Yang Ming Chiao Tung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shine-On BioMedical Co., Ltd.
Shine-On BioMedical Co., Ltd. BiotechnologyHealth Technology Manufactures drugs, antibodies and therapeutics | Health Technology |
- Stock Market
- Insiders
- Sheng Wen Yeh
















